These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10357006)

  • 1. Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?
    He S; Bremme K; Blombäck M
    Blood Coagul Fibrinolysis; 1999 Apr; 10(3):127-32. PubMed ID: 10357006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia.
    Uckan K; Sahin HG
    J Obstet Gynaecol Res; 2018 Mar; 44(3):440-447. PubMed ID: 29345041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.
    Higgins JR; Walshe JJ; Darling MR; Norris L; Bonnar J
    Am J Obstet Gynecol; 1998 Aug; 179(2):520-6. PubMed ID: 9731863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.
    Cadroy Y; Grandjean H; Pichon J; Desprats R; Berrebi A; Fournié A; Boneu B
    Br J Obstet Gynaecol; 1993 May; 100(5):416-20. PubMed ID: 8518239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.
    Hulstein JJ; van Runnard Heimel PJ; Franx A; Lenting PJ; Bruinse HW; Silence K; de Groot PG; Fijnheer R
    J Thromb Haemost; 2006 Dec; 4(12):2569-75. PubMed ID: 16968329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ceramide is increased and associated with proteinuria in women with pre-eclampsia and HELLP syndrome.
    Amraoui F; Hassani Lahsinoui H; Spijkers LJA; Vogt L; Peters SLM; Wijesinghe DS; Warncke UO; Chalfant CE; Ris-Stalpers C; van den Born BH; Afink GB
    Pregnancy Hypertens; 2020 Jan; 19():100-105. PubMed ID: 31927322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A; Bonnar J; Sheppard B; Darling M; Walshe J
    Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
    Hofmann M; Casper F; Prellwitz W; Brockerhoff P
    Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile of serum soluble endoglin in pregnant women with severe pre-eclampsia and eclampsia].
    Zhu YC; Sun Y; Yang HX; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):91-3. PubMed ID: 19570416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a decrease in antithrombin III activity with a perinatal elevation in aspartate aminotransferase in women with twin pregnancies: relevance to the HELLP syndrome.
    Minakami H; Watanabe T; Izumi A; Matsubara S; Koike T; Sayama M; Moriyama I; Sato I
    J Hepatol; 1999 Apr; 30(4):603-11. PubMed ID: 10207801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma antithrombin III levels in pre-eclampsia and chronic hypertension.
    Leiberman JR; Hagay ZJ; Mazor M; Wiznitzer A; Aharon M; Nathan I; Dvilansky A
    Int J Gynaecol Obstet; 1988 Aug; 27(1):21-4. PubMed ID: 2905294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation.
    Witsenburg CP; Rosendaal FR; Middeldorp JM; Van der Meer FJ; Scherjon SA
    Thromb Res; 2005; 115(5):387-92. PubMed ID: 15733972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia.
    Hayashi M; Inoue T; Hoshimoto K; Negishi H; Ohkura T; Inaba N
    Eur J Haematol; 2002; 69(5-6):297-302. PubMed ID: 12460234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia.
    He S; Bremme K; Blombäck M
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):232-8. PubMed ID: 9199820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study.
    Colmenares-Mejía CC; Quintero-Lesmes DC; Bautista-Niño PK; Guio Mahecha E; Beltrán Avendaño M; Díaz Martínez LA; Ortiz Serrano R; Páez Leal MC; Monterrosa Castro Á; Mesa Restrepo CM; Monsalve G; Sanín-Blair E; Saldarriaga W; Luna ML; Casas JP; Serrano Díaz N
    Hypertens Res; 2020 Sep; 43(9):884-891. PubMed ID: 32284540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
    Dati F; Pelzer H; Wagner C
    Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced thrombin generation in normal and hypertensive pregnancy.
    de Boer K; ten Cate JW; Sturk A; Borm JJ; Treffers PE
    Am J Obstet Gynecol; 1989 Jan; 160(1):95-100. PubMed ID: 2521425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble adhesion molecules in patients with pre-eclampsia].
    Krauss T; Osmers R; Beran J; Diedrich F; Fleckenstein G; Kuhn W
    Zentralbl Gynakol; 1998; 120(6):279-83. PubMed ID: 9659698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil oxygen radical production in pre-eclampsia with HELLP syndrome.
    Zusterzeel PL; Wanten GJ; Peters WH; Merkus HM; Steegers EA
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):213-8. PubMed ID: 11788174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome.
    Bussen S; Bussen D
    Arch Gynecol Obstet; 2011 Sep; 284(3):551-7. PubMed ID: 20941502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.